COVID-19 vaccine Covaxin offers protection against Beta, Delta variants: early study - World News

2021-06-09 12:35:27 GMT2021-06-09 20:35:27(Beijing Time) Xinhua English
NEW DELHI, June 9 (Xinhua) -- A joint study by researchers from Pune's National Institute of Virology, the Indian Council of Medical Research (ICMR) and Bharat Biotech has found that the country's indigenous COVID-19 vaccine, Covaxin, offers protection against the Beta (B.1.351) and the Delta (B.1.617.2) variants, local media reports said Wednesday.
The Delta variant (B.1.617.2) was first found in India and is the dominant strain in the country. The strain caused the deadly second wave in the country. The Beta variant (B.1.351) was first discovered in South Africa.
The study evaluated the neutralisation potential of sera collected from 20 COVID-19 recovered cases and 17 people vaccinated with two doses of Covaxin against Beta and Delta variants and compared it with the prototype D614G variant.

Related Keywords

South Africa ,India ,Pune ,Maharashtra ,Bharat ,Balram Bhargava ,Pragya Yadav ,Serum Institute Covishield ,Indian Council Of Medical Research ,Astrazeneca Oxford University Covishield ,Serum Institute Of India ,Pune National Institute Of Virology ,National Institute ,Indian Council ,Medical Research ,Bharat Biotech ,Serum Institute ,Coronavirus Vaccine Induced Antibody Titre ,Astrazeneca Oxford University , ,இந்தியா ,புனே ,மகாராஷ்டிரா ,பாரத் ,பால்ராம் பார்கவா ,பிராகிய யாதவ் ,இந்தியன் சபை ஆஃப் மருத்துவ ஆராய்ச்சி ,சீரம் நிறுவனம் ஆஃப் இந்தியா ,புனே தேசிய நிறுவனம் ஆஃப் வைராலஜி ,தேசிய நிறுவனம் ,இந்தியன் சபை ,மருத்துவ ஆராய்ச்சி ,பாரத் பயோடெக் ,சீரம் நிறுவனம் ,